Quality management is a key part of biologics development, especially when sponsors work with external manufacturers for research, development, and production activities. Clear responsibility allocation
Biopharmaceutical manufacturing requires a careful balance between production efficiency and product quality. As development projects move from laboratory research to clinical and commercial stages, companies
Preparing for FDA meetings before an IND submission is an important step for biotech companies developing biologics. These discussions allow sponsors to communicate development plans,
Drug development involves large amounts of scientific and operational data. From research records and process information to quality documents and submission materials, every dataset plays
